lanreotide acetate
PolandDrugs containing this active substance
-
The medicine is used for the long-term treatment of acromegaly (to relieve its symptoms, such as headaches, fatigue, or sweating) and in the treatment and inhibition of growth of certain advanced neuroendocrine tumors of the intestine and pancreas. It also helps to relieve hot flashes and diarrhea in patients with neuroendocrine tumors.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 71.5 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
This medicine is used for the long-term treatment of acromegaly (a condition involving excess growth hormone) and to inhibit the growth of certain advanced neuroendocrine tumors in the intestines and pancreas. It also helps relieve symptoms such as hot flashes, diarrhea, fatigue, headaches, or joint pain.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 107.2 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used for the long-term treatment of acromegaly (to relieve its symptoms, such as headaches, fatigue, or sweating) and for the treatment and inhibition of growth of certain advanced neuroendocrine tumors of the intestine and pancreas. It also helps to relieve hot flashes and diarrhea in patients with neuroendocrine tumors.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 143.0 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
This medicine is used for the long-term treatment of acromegaly (excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestine and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 71.5 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used for the long-term treatment of acromegaly (excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used for the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 107.2 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used for the long-term treatment of acromegaly (a condition of excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or sweating. It is also used for the treatment and inhibition of growth of advanced neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NET) and to relieve symptoms such as hot flashes and diarrhea in patients with these tumors.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 143 mg ATC: H01CB03
Manufacturer: Sun Pharmaceutical Industries Europe B.V., Terapia S.A.
-
The medicine is used to treat acromegaly, to relieve hot flashes and diarrhea in patients with neuroendocrine tumors, and to treat and inhibit the growth of certain advanced gastrointestinal endocrine tumors (GEP-NET) that cannot be surgically removed.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 66.67 mg ATC: H01CB03
Manufacturer: Pharmathen International S.A.
-
The medicine is used for the treatment of acromegaly, for the relief of hot flashes and diarrhea in patients with neuroendocrine tumors, and for the treatment and inhibition of growth of certain advanced gastrointestinal neuroendocrine tumors (GEP-NETs) that cannot be surgically removed.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 100 mg ATC: H01CB03
Manufacturer: Pharmathen International S.A.
-
The medicine is used for the treatment of acromegaly, to relieve symptoms such as hot flashes and diarrhea in patients with neuroendocrine tumors, and for the treatment and inhibition of growth of certain advanced gastrointestinal neuroendocrine tumors (GEP-NET) that cannot be surgically removed.
Form: solution for injection in ampoule-syringe
Active substance Dosage lanreotide acetate 133.33 mg ATC: H01CB03
Manufacturer: Pharmathen International S.A.
-
The medicine is used for the long-term treatment of acromegaly (excessive secretion of growth hormone) and to relieve symptoms associated with this disease, such as headaches, fatigue, or joint pain. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) in patients with neuroendocrine tumors.
Form: solution for injection
Active substance Dosage lanreotide acetate 79.8 mg ATC: H01CB03
Manufacturer: Ipsen Pharma Biotech SAS
-
The medicine is used for the long-term treatment of acromegaly (a condition of excess growth hormone) and to relieve its symptoms, such as headaches, fatigue, or joint pain. It is also used in the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestines and pancreas, and to relieve symptoms (e.g., hot flashes and diarrhea) associated with these tumors.
Form: solution for injection
Active substance Dosage lanreotide acetate 116.4 mg ATC: H01CB03
Manufacturer: Ipsen Pharma Biotech SAS
-
The medicine is used for the long-term treatment of acromegaly (to reduce excess growth hormone and alleviate its symptoms, such as headaches or fatigue) and for the treatment and inhibition of growth of certain advanced neuroendocrine tumors in the intestine and pancreas (when they cannot be surgically removed). It also helps to alleviate hot flashes and diarrhea in patients with neuroendocrine tumors.
Form: solution for injection
Active substance Dosage lanreotide acetate 155.45 mg ATC: H01CB03
Manufacturer: Ipsen Pharma Biotech SAS